申请人:Universita Degli Studi di Firenze
公开号:EP1118612A1
公开(公告)日:2001-07-25
Piperazine derivatives with general structure (I) are described. There:
R1 can be H or C1-5 alkyl;
R2 and R3 are both H or linked together to form a bridge -CH2-;
X can be H, F, OCH3, Cl, NO2, NH2, CH3;
Z can be CO, SO2.
The compounds described above are endowed with an interesting nootropic activity that makes them suitable to treat neurodegenerative diseases such as Alzheimer's disease.
描述了具有一般结构 (I) 的哌嗪衍生物。其中
R1 可以是 H 或 C1-5 烷基;
R2 和 R3 都是 H 或连接在一起形成桥 -CH2-;
X可以是H、F、OCH3、Cl、NO2、NH2、CH3;
Z 可以是 CO、SO2。
上述化合物具有有趣的促智活性,适合治疗神经退行性疾病,如阿尔茨海默病。